Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$4.58 - $9.21 $160,300 - $322,350
35,000 New
35,000 $241,000
Q2 2022

Aug 15, 2022

SELL
$7.06 - $23.63 $148,683 - $497,647
-21,060 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$21.6 - $27.79 $344,606 - $443,361
-15,954 Reduced 43.1%
21,060 $481,000
Q4 2021

Feb 14, 2022

BUY
$23.0 - $29.01 $851,322 - $1.07 Million
37,014 New
37,014 $1.02 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.